Skip to main content

Table 3 PRT rates in last 30 and 14 days of life by primary cancer diagnosis

From: Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study

Primary cancer diagnosis

Study cohort

Last 30 days

Last 14 days

  

Decedents

% cohort

% PRT

# course

Decedents

% cohort

% PRT

# course

Lung

2,406

272

11.3

24.7

357

129

5.4

11.7

160

Breast

1,204

42

3.5

17.8

54

18

1.5

7.6

20

Colorectal

1,551

30

1.9

21.7

33

16

1.0

11.6

18

Prostate

1,438

43

3.0

19.7

53

20

1.4

9.2

24

Non-colorectal GI

1,454

59

4.1

24.0

69

23

1.6

9.3

24

Blood

938

34

3.6

23.3

50

9

1.0

6.2

17

Urinary

656

36

5.5

24.2

45

11

1.7

7.4

15

Female genital

623

15

2.4

14.3

15

5

0.8

4.8

5

Brain

255

8

3.1

17.8

9

*

*

8.9

*

Melanoma

265

13

4.9

23.2

16

*

*

7.1

*

Other

1,510

62

4.1

26.8

80

29

1.9

12.6

37

Overall

12,300

614

5.0

23.0

781

268

2.2

10.0

328

  1. % cohort: Proportion of decedents received PRT in their last 30/14 days of life.
  2. % PRT: Proportion of decedents who receive PRT courses in last year of life received PRT in their last 30/14 days of life.
  3. #course: Number of PRT courses that decedents received in their last 30/14 days of life.
  4. *Cell is suppressed due to small count.